Abstract

As healthcare use of  cannabis is increasingly legalized worldwide, a much better understanding of the healthcare and hazardous effects of this drug is crucial. The discomfort associated with rheumatic illnesses is regarded as a prevalent indication for medicinal  cannabis in numerous nations. Hence far, preliminary clinical trials have explored the effects of  cannabis on rheumatoid arthritis, osteoarthritis and fibromyalgia preliminary proof has also identified an association in between the cannabinoid technique and other rheumatic situations, which includes systemic sclerosis and juvenile idiopathic arthritis. The prospective medicinal effects of  cannabis could be attributable to its influence on the immune technique, as it exerts an immunomodulatory impact on numerous immune cells, which includes T cells, B cells and macrophages. Nonetheless, the obtainable proof is not however enough to help the recommendation of cannabinoid therapy for rheumatic illnesses.

Copyright © 2018 Elsevier B.V. All rights reserved.

 

 

Supply:Pubmed

 

Katz-Talmor D1,two, Katz I1,three, Porat-Katz BS1,four, Shoenfeld Yfive,six.